However, women who had both their ovaries removed but were treated with estrogen until at least age 50 did not have any increased risk. The study, which includes follow-up for more that 30 years and interviews with nearly 3,000 women, will appear in the Aug. 29 online edition of Neurology, the medical journal of the American Academy of Neurology.
This research helps clarify questions about the health role of estrogen before the age of natural menopause and estrogen’s ability to protect brain functioning. This study is among the first to provide significant epidemiological evidence supporting the neurological benefits of ovarian preservation in young women and the neuroprotective role of estrogen in younger women.
Significance of the Mayo Clinic Research
“This study is one of the first to obtain large-scale data about neurological diseases in women who had their ovaries removed,” explains Walter Rocca, M.D., Mayo Clinic neurologist, epidemiologist and lead author of the study. “Our findings will contribute to a better understanding of the advantages and disadvantages of removing the ovaries in young women. In addition, our findings suggest that there is a window of therapeutic opportunity for prescribing estrogen replacement therapy in women who undergo ovary removal before age 50. This window of opportunity is before the approximate age of naturally occurring menopause, when the benefits of neuroprotection are likely to outweigh the risks of side effects of estrogen therapy.” By contrast, other studies have shown that when estrogen treatment is started after age 60 to 65, the risk of heart problems, stroke and cognitive impairment or dementia is increased.
Research results also showed that the risk for cognitive impairment or dementia increased the younger the woman was at ovary removal. “Adverse results increased for women who were of a younger age at surgery, and were the same regardless of reason for ovary removal. Somewhat more surprising, cognitive impairment was observed even in women who had only one ovary removed,” explains Dr. Rocca.
Implications for Patient Care
The study may have important medical implications for women facing choices about ovary removal and estrogen treatment after the surgery.
“In every medical or surgical decision there is a trade-off between risks and benefits,” says Bobbie Gostout, M.D., a Mayo Clinic gynecological and obstetrical surgeon. “Therefore, a woman considering ovary removal should discuss these findings with her physician prior to the surgery to consider the long-term implications and the possible strategies for estrogen treatment following the surgery.
“In view of this new information, careful individualized counseling is necessary to help women make informed decisions. When oophorectomy (ovary removal) is indicated in a young woman, it is important to carefully educate that patient regarding estrogen replacement. Unless clear contraindications are present, most women should be advised to take estrogen therapy until approximately age 50,” explains Dr. Gostout.
About the Study
Mayo Clinic is home to the Rochester Epidemiology Project, which collects medical records beginning in 1935, and is now one of the largest long-term integrated databases of patient records in the world. The Mayo Clinic team used the system to identify all the women in Olmsted County, Minn., who had one or both ovaries removed -- 1,489 women -- between 1950 and 1987.
These women were matched by age with an equal number of women who did not have ovarian surgery (1,472). Researchers then interviewed women in both groups (or their relatives) and compared the risk of cognitive impairment or dementia between the two groups, until the time of death. Women who were alive were interviewed in person and underwent a cognitive test over the telephone. For women who had died, a family member was interviewed.
Multi-year study finds 'hotspots' of ammonia over world's major agricultural areas
17.03.2017 | University of Maryland
Diabetes Drug May Improve Bone Fat-induced Defects of Fracture Healing
17.03.2017 | Deutsches Institut für Ernährungsforschung Potsdam-Rehbrücke
Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.
The results will be published on March 22 in the journal „Astronomy & Astrophysics“.
Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...
Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.
Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...
In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...
Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.
Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...
Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.
Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...
20.03.2017 | Event News
14.03.2017 | Event News
07.03.2017 | Event News
23.03.2017 | Life Sciences
23.03.2017 | Power and Electrical Engineering
23.03.2017 | Earth Sciences